Andrej Orszag

1.6k total citations
49 papers, 1.1k citations indexed

About

Andrej Orszag is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Andrej Orszag has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Cardiology and Cardiovascular Medicine and 15 papers in Physiology. Recurrent topics in Andrej Orszag's work include Diabetes Management and Research (17 papers), Pain Mechanisms and Treatments (13 papers) and Diabetes and associated disorders (12 papers). Andrej Orszag is often cited by papers focused on Diabetes Management and Research (17 papers), Pain Mechanisms and Treatments (13 papers) and Diabetes and associated disorders (12 papers). Andrej Orszag collaborates with scholars based in Canada, United States and Saudi Arabia. Andrej Orszag's co-authors include Bruce A. Perkins, Vera Bril, Madeline Ngo, Ausma Ahmed, Leif E. Lovblom, Eduardo Ng, Steven Orlov, E. Ng, Alanna Weisman and Elise M. Halpern and has published in prestigious journals such as Nature Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Andrej Orszag

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrej Orszag Canada 18 380 340 332 329 244 49 1.1k
Hassan Fadavi United Kingdom 22 987 2.6× 244 0.7× 774 2.3× 834 2.5× 538 2.2× 33 2.0k
Madeline Ngo Canada 19 312 0.8× 186 0.5× 507 1.5× 261 0.8× 362 1.5× 35 1.1k
Adnan Khan Qatar 18 297 0.8× 178 0.5× 287 0.9× 301 0.9× 223 0.9× 62 932
Gabriele Fuchsjäger‐Mayrl Austria 19 68 0.2× 81 0.2× 121 0.4× 699 2.1× 364 1.5× 35 1.0k
Alise Kalteniece United Kingdom 19 422 1.1× 90 0.3× 260 0.8× 323 1.0× 208 0.9× 38 823
Tushar Issar Australia 13 154 0.4× 82 0.2× 133 0.4× 98 0.3× 114 0.5× 28 485
Yoon Hi Cho Australia 16 25 0.1× 438 1.3× 121 0.4× 88 0.3× 69 0.3× 34 796
Cristian Quattrini United Kingdom 9 195 0.5× 173 0.5× 408 1.2× 176 0.5× 142 0.6× 9 773
A. K. Asbury United States 7 33 0.1× 140 0.4× 420 1.3× 36 0.1× 153 0.6× 9 1.1k
G. Krzentowski Belgium 15 30 0.1× 290 0.9× 244 0.7× 131 0.4× 101 0.4× 27 817

Countries citing papers authored by Andrej Orszag

Since Specialization
Citations

This map shows the geographic impact of Andrej Orszag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Orszag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Orszag more than expected).

Fields of papers citing papers by Andrej Orszag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrej Orszag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Orszag. The network helps show where Andrej Orszag may publish in the future.

Co-authorship network of co-authors of Andrej Orszag

This figure shows the co-authorship network connecting the top 25 collaborators of Andrej Orszag. A scholar is included among the top collaborators of Andrej Orszag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrej Orszag. Andrej Orszag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bapat, Priya, Andrej Orszag, David Z.I. Cherney, et al.. (2025). Longitudinal Determination of Diabetes Complications and Other Clinical Variables as Risk Factors for Diabetic Ketoacidosis in Type 1 Diabetes. Diabetes Care. 48(4). 614–622. 1 indexed citations
2.
Bapat, Priya, et al.. (2024). 1440-P: C-Peptide Preservation and Diabetic Ketoacidosis (DKA) Risk in Type 1 Diabetes. Diabetes. 73(Supplement_1). 1 indexed citations
3.
Bapat, Priya, Andrej Orszag, David Z.I. Cherney, et al.. (2024). Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related Complications. Canadian Journal of Diabetes. 48(7). 462–470.e3.
4.
Bapat, Priya, Andrej Orszag, David Z.I. Cherney, et al.. (2024). Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades. Diabetes Technology & Therapeutics. 27(2). 139–143. 3 indexed citations
5.
Haidar, Ahmad, Leif Erik Lovblom, Andrej Orszag, et al.. (2022). Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial. Nature Medicine. 28(6). 1269–1276. 26 indexed citations
6.
Lovblom, Leif E., et al.. (2020). The Prevalence of Autoimmune Diseases in Longstanding Diabetes: Results from the Canadian Study of Longevity in Adults with Type 1 Diabetes. Canadian Journal of Diabetes. 45(6). 512–518.e1. 5 indexed citations
7.
Piani, Federica, Yuliya Lytvyn, Leif Erik Lovblom, et al.. (2020). Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease. Journal of Diabetes and its Complications. 35(3). 107807–107807. 8 indexed citations
8.
Lovblom, Leif Erik, et al.. (2019). Sex differences in neuropathy & neuropathic pain: A brief report from the Phase 2 Canadian Study of Longevity in Type 1 Diabetes. Journal of Diabetes and its Complications. 33(12). 107397–107397. 16 indexed citations
9.
Bjornstad, Petter, Julie A. Lovshin, Yuliya Lytvyn, et al.. (2019). Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report. Journal of Diabetes and its Complications. 33(8). 547–549. 1 indexed citations
10.
Scarr, Daniel, Petter Bjornstad, Leif E. Lovblom, et al.. (2019). Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes. Kidney International Reports. 4(6). 786–796. 14 indexed citations
11.
Lovblom, Leif E., Johnny-Wei Bai, Evan J.H. Lewis, et al.. (2018). Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes. Journal of Diabetes and its Complications. 32(7). 660–664. 27 indexed citations
12.
Lovblom, Leif E., Elise M. Halpern, Ausma Ahmed, et al.. (2015). In Vivo Corneal Confocal Microscopy and Prediction of Future-Incident Neuropathy in Type 1 Diabetes: A Preliminary Longitudinal Analysis. Canadian Journal of Diabetes. 39(5). 390–397. 48 indexed citations
13.
Lovblom, Leif E., Mohammed A. Farooqi, Daniel Scarr, et al.. (2015). Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy. PLoS ONE. 10(11). e0142309–e0142309. 32 indexed citations
14.
Farooqi, Mohammed A., Leif E. Lovblom, Elise M. Halpern, et al.. (2015). Validation of cooling detection threshold as a marker of sensorimotor polyneuropathy in type 2 diabetes. Journal of Diabetes and its Complications. 30(4). 716–722. 16 indexed citations
15.
Lovblom, Leif E., Elise M. Halpern, Madeline Ngo, et al.. (2014). Measurement of Cooling Detection Thresholds for Identification of Diabetic Sensorimotor Polyneuropathy in Type 1 Diabetes. PLoS ONE. 9(9). e106995–e106995. 8 indexed citations
16.
Weisman, Alanna, Vera Bril, Madeline Ngo, et al.. (2013). Identification and Prediction of Diabetic Sensorimotor Polyneuropathy Using Individual and Simple Combinations of Nerve Conduction Study Parameters. PLoS ONE. 8(3). e58783–e58783. 64 indexed citations
17.
Ahmed, Ausma, et al.. (2012). Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening. Diabetic Medicine. 29(9). e297–303. 57 indexed citations
18.
Nouri, Maryam Nabavi, Ausma Ahmed, Vera Bril, et al.. (2012). Diabetic Neuropathy and Axon Reflex-Mediated Neurogenic Vasodilatation in Type 1 Diabetes. PLoS ONE. 7(4). e34807–e34807. 26 indexed citations
19.
20.
Hertz, Paul, Vera Bril, Andrej Orszag, et al.. (2011). Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabetic Medicine. 28(10). 1253–1260. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Fadavi Breakdown of academic impact, for papers by Madeline Ngo Breakdown of academic impact, for papers by Adnan Khan Breakdown of academic impact, for papers by Gabriele Fuchsjäger‐Mayrl Breakdown of academic impact, for papers by Alise Kalteniece Breakdown of academic impact, for papers by Tushar Issar Breakdown of academic impact, for papers by Yoon Hi Cho Breakdown of academic impact, for papers by Cristian Quattrini Breakdown of academic impact, for papers by A. K. Asbury Breakdown of academic impact, for papers by G. Krzentowski
Rankless by CCL
2026